Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Identifying Markers of Efficacy to Immunotherapy in Patients With Metastatic Melanoma: the PREMIO Study

NCT07794501 is registered in ClinicalTrials.gov with European Institute of Oncology as lead sponsor.

NCT NCT07794501
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07794501 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Identifying Markers of Efficacy to Immunotherapy in Patients With Metastatic Melanoma: the PREMIO Study
Lead sponsor
European Institute of Oncology
Phase
Observational
Overall status
Not yet recruiting
Start date
August 27, 2026
Completion date
November 30, 2027
Enrollment
200 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic melanoma